This summary covers various global health concerns, including Brazil’s bird flu prompts on trade restrictions, Novartis’s potential acquisition of Avidity Biosciences, Merck KGaA’s updated earnings guidance, and FDA’s approval of a Jazz Pharmaceuticals drug. It also highlights the dire water and malnutrition crisis in Gaza after prolonged conflict.
